Delays in diagnosis of head and neck cancers

被引:0
|
作者
Yu, Thomas [1 ,2 ]
Wood, Robert E. [3 ]
Tenenbaum, Howard C. [4 ]
机构
[1] Univ Toronto, Toronto, ON, Canada
[2] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
[3] Univ Hlth Network, Princess Margaret Hosp, Dept Dent Oncol Ocular & Maxillofacial Prosthet, Toronto, ON, Canada
[4] Univ Toronto, Mt Sinai Hosp, Dept Dent, Div Res,Fac Med,Lab Med & Pathobiol,Fac Dent, Toronto, ON M5G 1X5, Canada
来源
JOURNAL OF THE CANADIAN DENTAL ASSOCIATION | 2008年 / 74卷 / 01期
关键词
D O I
暂无
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Delayed diagnosis of head and neck cancer is often caused by patient-related factors. However, the primary health care provider may also be responsible. Objectives: To define patient, professional and total delay, and to identify factors that may increase delay. Methods: The study group consisted of 102 patients with oral or pharyngeal cancer referred to Princess Margaret Hospital, Toronto, Ontario. The study took place from September 2005 to September 2006. Results: Median patient, professional and total delays were 4.5 weeks, 11.8 weeks and 22.5 weeks, respectively. Significantly longer delays were found among women (p < 0.01), non-smokers (p < 0.01), patients who were not referred following initial consultation (p < 0.001) and patients who did not visit their dentist (p < 0.05). Conclusions: Clinicians should adopt a "universal index of suspicion" in screening for head and neck cancer, with attention to the risk indicators for delay. Patients must also be encouraged to visit their dentist regularly to increase the rate of early detection.
引用
收藏
页码:61 / 61C
页数:4
相关论文
共 50 条
  • [21] Protein glycosylation in head and neck cancers: From diagnosis to treatment
    Rasheduzzaman, Mohammad
    Kulasinghe, Arutha
    Dolcetti, Riccardo
    Kenny, Liz
    Johnson, Newell W.
    Kolarich, Daniel
    Punyadeera, Chamindie
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1874 (02):
  • [22] IMMUNOLOGY OF HEAD AND NECK CANCERS
    NEWBILL, ET
    JOHNS, ME
    CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1983, 19 (01): : 1 - 25
  • [23] Anemia in head and neck cancers
    Azria, D
    Zouhair, A
    Serre, A
    Lemanski, C
    Schneider, M
    Ozsahin, M
    Dubois, JB
    Lartigau, E
    BULLETIN DU CANCER, 2005, 92 (05) : 445 - 451
  • [24] Biology of head and neck cancers
    Weichert, W.
    ONKOLOGIE, 2010, 33 : 89 - 90
  • [25] Head and neck cancers in India
    Dandekar, Mitali
    Tuljapurkar, Vidisha
    Dhar, Harsh
    Panwar, Aru
    DCruz, Anil K.
    JOURNAL OF SURGICAL ONCOLOGY, 2017, 115 (05) : 555 - 563
  • [26] EPIDEMIOLOGY OF HEAD AND NECK CANCERS
    SANGHVI, LD
    RAO, DN
    JOSHI, S
    SEMINARS IN SURGICAL ONCOLOGY, 1989, 5 (05): : 305 - 309
  • [27] REIRRADIATION IN HEAD AND NECK CANCERS
    Nieto, I.
    Miriam, L. M.
    Munoz, V.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S329 - S329
  • [28] Herpesviruses in Head and Neck Cancers
    Wolacewicz, Mikolaj
    Becht, Rafal
    Grywalska, Ewelina
    Niedzwiedzka-Rystwej, Paulina
    VIRUSES-BASEL, 2020, 12 (02):
  • [29] Brachytherapy for head and neck cancers
    Lapeyre, M.
    Coche-Dequeant, B.
    Moreira, J-F
    Le Bourhis, J.
    Peiffert, D.
    CANCER RADIOTHERAPIE, 2013, 17 (02): : 130 - 135
  • [30] Reirradiation of head and neck cancers
    Doyen, J.
    Kee, D. Lam Cham
    Krebs, L.
    Guigay, J.
    Dassonville, O.
    Peyrade, F.
    Poissonnet, G.
    Saada-Bouzid, E.
    Sudaka, A.
    Bozec, A.
    Benezery, K.
    CANCER RADIOTHERAPIE, 2017, 21 (6-7): : 521 - 526